Nanoparticles of cobalt-substituted hydroxyapatite in regeneration of mandibular osteoporotic bones

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 2, 2013, Pages 343-354

  Ignjatović, Nenad ^a   Ajduković, Zorica ^b   Savić, Vojin ^b   Najman, Stevo ^b   Mihailović, Dragan ^b   Vasiljević, Perica ^b   Stojanović, Zoran ^a   Uskoković, Vuk ^c   Uskoković, Dragan ^a  

^a INSTITUTE OF TECHNICAL SCIENCES   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE TISSUE REGENERATION; EPITHELIAL CACO-2 CELLS; EPITHELIAL MONOLAYERS; HISTOLOGICAL ANALYSIS; HYDROXYAPATITE NANOPARTICLES; NANO PARTICULATES; OSTEOBLASTIC CELLS;

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; COBALT; COBALT COMPOUNDS; DEFECT DENSITY; HYDROXYAPATITE; MONOLAYERS; NANOPARTICLES; PARAMAGNETISM; PHOSPHATASES;

BONE;

ALKALINE PHOSPHATASE; COBALT; HYDROXYAPATITE; NANOPARTICLE;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLOOD AUTOTRANSFUSION; BONE DENSITY; BONE REGENERATION; BONE TISSUE; CELL STRAIN CACO 2; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; JAW MALFORMATION; MOUSE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; RAT; TISSUE REGENERATION;

ANIMALS; BONE REGENERATION; CACO-2 CELLS; CELLS, CULTURED; COBALT; DURAPATITE; FEMALE; GUIDED TISSUE REGENERATION; HUMANS; JAW DISEASES; MANDIBLE; MANDIBULAR RECONSTRUCTION; METAL NANOPARTICLES; MICE; OSTEOPOROSIS; RATS; RATS, WISTAR;

RATTUS;

EID: 84878374725     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4793-1     Document Type: Article

References (46)

1. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115:3318-25.
2. Pollähne W, Pfeifer M, Lazarescu A, Minne HW. Osteoporose: bildgebende diagnostik. Medizin im Bild. 1996;3:37-44.
3. Marco F, Milena F, Gianluca G, Vittoria O. Peri-implant osteogenesis in health and osteoporosis. Micron. 2005;36(7-8):630-44.
4. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26(18):3995-4021.
5. Ito A, Honda H, Kobayasji T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression. Cancer Immunol Immunother. 2006;55(3):320-8.
6. Hench LL. Bioceramics. J Am Ceram Soc. 1998;81(7):1705-28.
7. Le Geros RZ, Craig RG. Strategies to affect bone remodeling: osteointegration. J Bone Miner Res. 1993;8(2):S583-96.
8. Ajdukovic Z, Ignjatovic N, Petrovic D, Uskokovic D. Substitution of osteoporotic alveolar bone by biphasic calcium phosphate/poly -DL-lactide-co-glycolide biomaterials. J Biomater Appl. 2007;21(3):317-28.
9. Ignjatovic N, Uskokovic D. Biodegradable composites based on nano-crystalline calcium phosphate and bioresorbable polymers. Adv Appl Ceram. 2008;107:142-7.
10. Abdel-Fattah WI, Osiris WG, Mohamed SS, Khalil MR. Reconstruction of resected mandibles using a hydroxyapatite veterinary bone graft. Biomaterials. 1994;15(8):609-14.
11. Tami AE, Leitner MM, Baucke MG, Mueller TL, van Lenthe GH, Müller R, Ito K. Hydroxyapatite particles maintain peri-implant bone mantle during osseointegration in osteoporotic bone. Bone. 2009;45(6):1117-24.
12. Verron E, Gauthier O, Janvier P, Pilet P, Lesoeur J, Bujoli B, Guicheux J, Bouler J-M. In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite. Biomaterials. 2010;31(30):7776-84.
13. Ignjatovic N, Ajdukovic Z, Savic V, Uskokovic D. Size effect of calcium phosphate coated with poly-(DL-lactide-co-glycolide) on healing processes in bone reconstruction. J Biomed Mater Res B Appl Biomater. 2010;94B:108-17.
14. Balasundaram G, Sato M, Webster TJ. Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials. 2006;27(14):2798-805.
15. Uskoković V, Uskoković DP. Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents. J Biomed Mater Res B Appl Biomater. 2011;96B(1):152-91.
16. Veselinovic LJ, Karanovic LJ, Stojanovic Z, Bracko I, Markovic S, Ignjatovic N, Uskokovic D. Crystal structure of cobalt-substituted calcium hydroxyapatite nanopowders prepared by hydrothermal processing. J Appl Crystallogr. 2010;43:320-7.
17. Zhang JM, Lin CJ, Feng ZD, Tian ZW. Hydroxyapatite/metal composite coatings prepared by multi-step electrodepozition method. J Mater Sci Lett. 1998;17:1077-9.
18. El Ouassouli A, Ezzemouri S, Ezzamarty A, Lakhdar M, Leglise J. Catalyseurs sulfures à base de cobalt et d'hydroxyapatite. J Chim Phys. 1999;96(7):1212-25.
19. Landi E, Tampieri A, Celotti G, Sprio S, Sandri M, Logroscin G. Sr-substituted hydroxyapatites for osteoporotic bone replacement. Acta Biomater. 2007;3(6):961-9.
20. Meng J, Zhang Y, Qi X, Kong H, Wang C, Xu Z, Xie S, Gu N, Xu H. Paramagnetic nanofibrous composite films enhance the osteogenic responses of pre-osteoblast cells. Nanoscale. 2010;2:2565-9.
21. Li Y, Nam CT, Ooi CP. Iron(III) and manganese (II) substituted hydroxyapatite nanoparticles: characterization and cytotoxicity analysis. J Phys Conf. Ser. 2009;. doi: 10.1088/1742-6596/187/1/012024.
22. Patel B, Favaro G, Inam F, Reece MJ, Angadji A, Bonfield W, Huang J, Edirisinghe M. Cobalt-based orthopaedic alloys: relationship between forming route, microstructure and tribological performance. Mater Sci Eng C. 2012;. doi: 10.1016/j.msec.2012.03.012.
23. Stojanovic Z, Veselinovic LJ, Markovic S, Ignjatovic N, Uskokovic D. Hydrothermal synthesis of nanosize pure and cobalt-exchanged hydroxyapatite. Mater Manuf Processes. 2009;24:1096-103.
24. Uskoković V, Lee PP, Walsh L, Fischer KE, Desai TA. Silicon Nanowire coated microparticles as epithelial drug delivery devices. The effect of PEGylation on particle-epithelium interactions. Biomaterials. 2012;33(5):1663-72.
25. Ajdukovic Z, Najman S, Djordjevic LJ, Savic V, Petrovic D, Ignjatovic N, Uskokovic D. Repair of bone tissue affected by osteoporosis with hydroxyapatite-poly-L-(HAp/PLLA) with and without blood plasma. J Biomater Appl. 2005;20(2):179-90.
26. Ignjatovic N, Ajdukovic Z, Uskokovic D. New biocomposite calciumphosphate/poly-DL-lactide-co-glycolide/biostimulatite agens filler for reconstruction of bone tissue changed by osteoporosis. J Mater Sci Mater Med. 2005;16:621-6.
27. Ignjatovic N, Ninkov P, Ajdukovic Z, Vasiljevic-Radovic D, Uskokovic D. Biphasic calcium phosphate coated with poly-D, L-lactide-co-glycolide biomaterial as a bone substitute. J Eur Ceram Soc. 2007;27(2-3):1589-94.
28. Miao D, Scutt A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem. 2002;50(3):333-40.
29. Britti D, Massimini G, Peli A, Luciani A, Boari A. Evaluation of serum enzyme activities as predictors of passive transfer status in lambs. J Am Vet Med Assoc. 2005;226(6):951-5.
30. Macleod I, Heath N. Cone-beam computed tomography (CBCT) in dental practice. Dent Update. 2008;35:590-8.
31. Suomalainen A, Kiljunen T, Käser Y, Peltola J, Kortesniemi M. Dosimetry and image quality of four dental cone beam computed tomography scanners compared with multislice computed tomography scanners. Dentomaxillofac Radiol. 2009;38(6):367-78.
32. Homolka P, Beer A, Birkfellner W, Nowotny R, Gahleitner A, Tschabitscher M, Bergmann H. Bone mineral density measurement with dental quantitative CT prior tu dental implant placement in cadaver mandibles: pilot study. Radipoly. 2002;224(1):247-52.
33. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998;273:29745-53.
34. Wittchen ES, Haskins J, Stevenson BR. Protein interactions at the tight junction. Actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J Biol Chem. 1999;274:35179-85.
35. Horev-Azaria L, Kirkpatrick CJ, Korenstein R, Marche PN, Maimon O, Ponti J, Romano R, Rossi F, Golla-Schindler U, Sommer D, Uboldi C, Unger RE, Villiers C. Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data. Toxicol Sci. 2011;122(2):489-501.
36. Yang SJ, Pyen J, Lee I, Lee H, Kim Y, Kim T. Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase 1/2 activation in rat C6 glioma cells. J Biochem Mol Biol. 2004;37(4):480-6.
37. Gürbay A. Protective effect of zinc chloride against cobalt chloride-induced cytotoxicity on vero cells: preliminary results. Biol Trace Elem Res. 2012;148(1):110-6.
38. de Lima IR, Alves GG, Soriano CA, Campaneli AP, Gasparoto TH, Ramos ES Jr, de Sena LÁ, Rossi AM, Granjeiro JM. Understanding the impact of divalent cation substitution on hydroxyapatite: an in vitro multiparametric study on biocompatibility. J Biomed Mater Res A. 2011;98(3):351-8. doi: 10.1002/jbm.a.33126.
39. Lantin AC, Mallants A, Vermeulen J, Speybroeck N, Hoet P, Lison D. Absence of adverse effect on thyroid function and red blood cells in a population of workers exposed to cobalt compounds. Toxicol Lett. 2011;201(1):42-6.
40. Pelclova D, Sklensky M, Janicek P, Lach K. Severe cobalt intoxication following hip replacement revision: clinical features and outcome. Clin Toxicol. 2012;50(4):262-5.
41. Hallab NJ, Chan FW, Harper ML, Quantifying subtle but persistent peri-spine inflammation in vivo to submicron cobalt-chromium alloy particles, Eur Spine J, 2012 Mar 10. [Epub ahead of print].
42. Gill HS, Grammatopoulos G, Adshead S, Tsialogiannis E, Tsiridis E. Molecular and immune toxicity of CoCr nanoparticles in MoM hip arthroplasty. Trends Mol Med. 2012;18(3):145-55.
43. D.B. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons. Biomaterials science. An Introduction to Materials in Medicine, 2nd Edition, Elsevier Academic Press San Diego, California, USA 2004:23-40
44. Seibel JM. Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis. Clin Biochem Rev. 2006;27(3):123-38.
45. Meunier PJ, Jenvrin C, Munoz F, de la Gueronniere V, Garnero P, Menz M. Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake. Osteoporos Int. 2005;16(10):1203-9.
46. Hen-Yu L, Alexander WTH, Ching-Yu T, Kuei-Ru C, Rong Z, Ming-Fu W, Wen-Chang C, Shiaw-Min H, Ching-Hua S, Win-Ping D. The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis. Biomaterials. 2011;32:6773-80.